Matthew Loft

Dr. Matthew Loft

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BLBelinda Lee
Belinda Lee
LGLucy Gately
Lucy Gately
SLSheau Wen Lok
Sheau Wen Lok
BTBen Tran
Ben Tran
MLMargaret Lee
Margaret Lee
PGPeter Gibbs
Peter Gibbs
Traditional cancer registries have often been siloed efforts, established by single groups with limited objectives. There is the potential for registry data to support a broad range of research, audit and education initiatives. Here, we describe the establishment of a series of comprehensive cancer registries across the spectrum of common solid cancers. The experience and learnings of each registry team as they develop, implement and then use collected data for a range of purposes, that informs the conduct and output of other registries in a virtuous cycle. Each registry is multi-site, multi-disciplinary and aims to collect data of maximal interest and value to a broad range of enquiry, which would be accessible to any researcher with a high-quality proposal. Lessons learnt include the need for careful and continuous curation of data fields, with regular database updates, and the need for a continued focus on data quality. The registry data as a standalone resource has supported numerous projects, but linkage with external datasets with patients in common has enhanced the audit and research potential. Multiple projects have linked registry data with matched tissue specimens to support prognostic and predictive biomarker studies, both validation and discovery. Registry-based biomarker trials have been successfully supported, generating novel and practice-changing data. Registry-based clinical trials, particularly randomised studies exploring the optimal use of available therapy options are now complementing the research conducted in traditional clinical trials. More recent projects supported by the registries include health economic studies, personalised patient education material, and increased consumer engagement, including consumer entered data.

9 January 2023 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MLMatthew Loft
Matthew Loft
SLSheau Wen Lok
Sheau Wen Lok
RBRichard De Boer
Richard De Boer
LMLaeeq Malik
Laeeq Malik
SGSally Greenberg
Sally Greenberg
LGLucy Gately
Lucy Gately

Verified
Journal Article
Open access
PDF file
MLMatthew Loft
Matthew Loft
BLBelinda Lee
Belinda Lee
JTJeanne Tie
Jeanne Tie
PGPeter Gibbs
Peter Gibbs
Pancreatic adenocarcinoma remains one of the most aggressive cancers with an ongoing dismal survival rate despite some recent advances in treatment options. This is largely due to the typically late presentation and limited effective therapeutic options in advanced disease. There are numerous circulating biomarkers that have potential clinical application as tumour markers, including circulating tumour DNA (ctDNA), circulating tumour cells (CTCs), cell-free RNA (cfRNA), exosomes and circulating tumour proteins. This review will focus on the development of ctDNA as a non-invasive liquid biopsy, with its high sensitivity and specificity having potential clinical applications in pancreatic cancer. These include a role in screening, prognostication via the detection of minimal residual disease, early detection of recurrence, and for patients with advanced disease; tumour genotyping and monitoring treatment response. Prospective randomised adjuvant clinical trials are currently underway, exploring the impact of ctDNA-guided adjuvant therapy decisions. In this review, we provide perspectives on the current literature and considerations of future directions.

8 September 2020 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
MLMatthew Loft
Matthew Loft
HWHui‐Li Wong
Hui‐Li Wong
SKSuzanne Kosmider
Suzanne Kosmider
MLMargaret Lee
Margaret Lee
JTJeanne Tie
Jeanne Tie
PGPeter Gibbs
Peter Gibbs

13 September 2022 in Internal Medicine Journal
Verified
Journal Article
Closed access
MLMatthew Loft
Matthew Loft
JSJeremy Shapiro
Jeremy Shapiro
MLMargaret Lee
Margaret Lee
RWRachel Wong
Rachel Wong
JTJeanne Tie
Jeanne Tie
PGPeter Gibbs
Peter Gibbs

18 November 2024 in Internal Medicine Journal
Verified
Journal Article
Closed access
MLMatthew Loft
Matthew Loft
VWVanessa Wong
Vanessa Wong
SKSuzanne Kosmider
Suzanne Kosmider
RWRachel Wong
Rachel Wong
JSJeremy Shapiro
Jeremy Shapiro
PGPeter Gibbs
Peter Gibbs